Evidence map›Paper›PMID 32960169›Full record

ArticleeLife2020

Integrase-RNA interactions underscore the critical role of integrase in HIV-1 virion morphogenesis.

Jennifer L Elliott, Jenna E Eschbach, Pratibha C Koneru, Wen Li, Maritza Puray-Chavez, Dana Townsend, Dana Q Lawson, Alan N Engelman, Mamuka Kvaratskhelia, Sebla B Kutluay

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 50 citations in OpenAlex.

  1. Mechanisms of HIV-1 assembly, release and maturation.Nature reviews. Microbiology · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Mapping the vRNA Interaction with HIV-1 Integrase.bioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jennifer L ElliottDepartment of Molecular Microbiology, Washington University School of Medicine, Saint Louis, United States.
Jenna E EschbachDepartment of Molecular Microbiology, Washington University School of Medicine, Saint Louis, United States.
Pratibha C KoneruDivision of Infectious Diseases, University of Colorado School of Medicine, Aurora, United States.ORCID 0000-0003-3955-4548
Wen LiDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, United States.
Maritza Puray-ChavezDepartment of Molecular Microbiology, Washington University School of Medicine, Saint Louis, United States.
Dana TownsendDepartment of Molecular Microbiology, Washington University School of Medicine, Saint Louis, United States.
Dana Q LawsonDepartment of Molecular Microbiology, Washington University School of Medicine, Saint Louis, United States.
Alan N EngelmanDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, United States.
Mamuka KvaratskheliaDivision of Infectious Diseases, University of Colorado School of Medicine, Aurora, United States.ORCID 0000-0003-3800-0033
Sebla B KutluayDepartment of Molecular Microbiology, Washington University School of Medicine, Saint Louis, United States.ORCID 0000-0001-5549-7032
Washington University in St. Louis · USHarvard University · USUniversity of Colorado Denver · US

Funding

The Center for HIV RNA Studies (CRNA)P50GM103297 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TELESNITSKY, ALICE · 2012 to 2016
$21.7M
X-ray Crystallographic Fragment Screening CoreU54AI150472 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI LYUMKIS, DMITRY · 2019 to 2021
$15.7M
The Center for HIV RNA Studies (CRNA)U54AI150470 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TELESNITSKY, ALICE · 2019 to 2021
$15.1M
Integrase Structural VirologyR01AI070042 · NIAID · DANA-FARBER CANCER INST · PI ENGELMAN, ALAN N. · 2006 to 2020
$7.2M
Structure and function of HIV-1 integraseR01AI062520 · NIAID · UNIVERSITY OF COLORADO DENVER · PI KVARATSKHELIA, MAMUKA · 2006 to 2020
$5.3M
REGULATION AND TARGETING OF HIV-1 INTEGRASE-RNA INTERACTIONSR01AI150497 · NIAID · WASHINGTON UNIVERSITY · PI Sebla B. Kutluay · 2020 to 2026
$2.9M
Multimeric HIV-1 Integrase InhibitorsR01AI143649 · NIAID · UNIVERSITY OF COLORADO DENVER · PI KVARATSKHELIA, MAMUKA · 2019 to 2023
$2.5M
REGULATION AND TARGETING OF HIV-1 INTEGRASE-RNA INTERACTIONSR01GM122458 · NIGMS · WASHINGTON UNIVERSITY · PI KUTLUAY, SEBLA B. · 2017 to 2019
$961k
Investigating the integration-independent role of HIV-1 integrase in the viral life cycle and virion morphogenesisF31AI143389 · NIAID · WASHINGTON UNIVERSITY · PI ELLIOTT, JENNIFER L · 2019 to 2020
$37k
NIAID NIH HHS F31 AI143389NIAID NIH HHS R01 AI062520NIAID NIH HHS R01 AI070042NIAID NIH HHS R01 AI143649NIAID NIH HHS R01 AI150497NIAID NIH HHS U54 AI150470NIAID NIH HHS U54 AI150472NIGMS NIH HHS P50 GM103297NIGMS NIH HHS R01 GM122458
6 · The paper itself

Abstract

A large number of human immunodeficiency virus 1 (HIV-1) integrase (IN) alterations, referred to as class II substitutions, exhibit pleiotropic effects during virus replication. However, the underlying mechanism for the class II phenotype is not known. Here we demonstrate that all tested class II IN substitutions compromised IN-RNA binding in virions by one of the three distinct mechanisms: (i) markedly reducing IN levels thus precluding the formation of IN complexes with viral RNA; (ii) adversely affecting functional IN multimerization and consequently impairing IN binding to viral RNA; and (iii) directly compromising IN-RNA interactions without substantially affecting IN levels or functional IN multimerization. Inhibition of IN-RNA interactions resulted in the mislocalization of viral ribonucleoprotein complexes outside the capsid lattice, which led to premature degradation of the viral genome and IN in target cells. Collectively, our studies uncover causal mechanisms for the class II phenotype and highlight an essential role of IN-RNA interactions for accurate virion maturation.

Indexed as

Virus ReplicationCapsidGenome, ViralHEK293 CellsHIV-1HIV InfectionsHIV IntegraseHumansPhenotypeProtein BindingProtein MultimerizationRibonucleoproteinsRNA, ViralVirionVirus IntegrationHIV Integrasep31 integrase protein, Human immunodeficiency virus 1RibonucleoproteinsRNA, ViralHIV-1humaninfectious diseaseIntegraseIntegrase-RNA interactionsmaturationmicrobiologyvirus

Identifiers

PMID32960169
PMCPMC7671690
OpenAlexW3087190549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.